title: Low carbohydrate ketogenic diet prevents the induction of diabetes using streptozotocin in rats.
abstract: Diabetes continues to be an overwhelmingly prevalent endocrine disorder that leads to several micro- and macrocomplications. It has been widely accepted that changes in dietary habits could induce or prevent the onset of diabetes. It is shown that low carbohydrate ketogenic diet (LCKD) is effective in the amelioration of many of the deleterious consequences of diabetes. However, its role in preventing the onset of diabetes is not understood. Therefore, this study is focused on the effect of LCKD in preventing the induction of diabetes using streptozotocin (STZ) in rats by biochemical and histological methods. Forty-two Wistar rats weighing 150-250 g were used in this study. The animals were divided into three groups: normal diet (ND), low carbohydrate ketogenic diet (LCKD), and high carbohydrate diet (HCD). Specific diets ad libitum were given to each group of animals for a period of 8 weeks. Each group was further subdivided into normal control, sham control and diabetic groups. Animals in the diabetic group were given a single intraperitoneal injection of STZ (55 mg/kg). All the animals were sacrificed 4 weeks after the injection of STZ. Daily measurements of food and water intake as well as weekly measurement of body weight were taken during the whole 12 weeks of the experiment. After injecting with STZ, the blood glucose level of all the groups increased significantly except for the group fed on LCKD (p value<0.01). Also, food intake, water intake and urine output were significantly increased in all groups except for the LCKD group (p value<0.01). There was also a significant decrease in the weight gain of the animals that were fed on a LCKD as compared to other groups (p value<0.05). Although, substantial decrease in the number of β cells was noticed in diabetic rats, there were no change in the number of β cells in the LCKD treated diabetic animals as compared to LCKD control group. The results presented in this study, therefore, suggests that LCKD prevents the development of diabetes using streptozotocin in rats.
authors.affiliation: Department of Anatomy, Faculty of Medicine, Health Sciences Center, Kuwait University, Kuwait.
authors.forename: A
authors.initials: A
authors.lastname: Al-Khalifa
authors.forename: T C
authors.initials: TC
authors.lastname: Mathew
authors.forename: N S
authors.initials: NS
authors.lastname: Al-Zaid
authors.forename: E
authors.initials: E
authors.lastname: Mathew
authors.forename: H
authors.initials: H
authors.lastname: Dashti
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D001835:Body Weight / Q000187:drug effects; D003921:Diabetes Mellitus, Experimental / Q000178:diet therapy / Q000209:etiology / Q000517:prevention & control*; D050528:Diet, Carbohydrate-Restricted; D055423:Diet, Ketogenic; D004040:Dietary Carbohydrates / Q000008:administration & dosage*; D004326:Drinking / Q000187:drug effects; D004435:Eating / Q000187:drug effects; D002149:Energy Intake / Q000187:drug effects; D007515:Islets of Langerhans / Q000187:drug effects / Q000473:pathology; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D014554:Urination / Q000187:drug effects
chemical_list: D001786:Blood Glucose; D004040:Dietary Carbohydrates